The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Development of techniques to determine extracellular matrix alterations in acute and chronic lung diseases and bioengineered tissues

Author

Summary, in English

Acute and chronic lung diseases are a major cause of global mortality. While pharmacological approaches exist, no therapies are curative. The only option at end-stage disease is lung transplantation which is hampered by a chronic shortage of donor organs. Therefore, there is a high interest to develop alternative approaches to use regenerative medicine approaches to generate new lung tissue in the lab or to deliver cells which can participate in structural repair. In parallel to this clinical need, these new technologies, and the animal models which are used to assess their efficacy, require the development of new evaluation methods.
One of the most important methods for evaluating these therapies is histological assessment, as it can provide direct information at the tissue and cellular level information across all stages of the bioengineered tissue: from manufacture through evaluation in pre-clinical animal models. However, many of these potential therapies are comprised of a mix of cells, extracellular matrix and biomaterials (i.e. polymers in the case of soft tissues). Standard histological approaches have been developed for use with native animal and human tissues and organs, based on chemical moieties which are ubiquitous in animal tissues (e.g. amine or carboxylic acid groups).
Biomaterials (e.g. synthetic or natural polymers), on the other hand, have diverse chemical moieties that may not always be compatible with standard fixatives and tissue processing. Furthermore, the chemical composition of the solutions used in fixation or tissue processing, even at trace amounts, may alter biomaterials which have been used for bioengineering tissue or in vitro models.
Therefore, this thesis aimed to develop new methods to histologically assess native and bioengineered lung tissue, with a particular focus on developing methods which preserve cell-extracellular matrix or cell-biomaterial interactions for light and electron-based microscopy.

Publishing year

2023

Language

English

Publication/Series

Lund University, Faculty of Medicine Doctoral Dissertation Series

Issue

2023:91

Document type

Dissertation

Publisher

Lund University, Faculty of Medicine

Topic

  • Cell and Molecular Biology
  • Engineering and Technology
  • Natural Sciences

Keywords

  • Histology
  • semi-quantive score system
  • Biomaterial
  • ARDS
  • animal model

Status

Published

Research group

  • Lung Bioengineering and Regeneration

Supervisor

ISBN/ISSN/Other

  • ISSN: 1652-8220
  • ISBN: 978-91-8021-431-5

Defence date

22 June 2023

Defence time

13:00

Defence place

Segerfalksalen, BMC A10, Sölvegatan 17 i Lund

Opponent

  • José Ángel Lorente Balanza (Professor)